Rapifen 500 micrograms/ml solution for injection or infusion Ref.[2472] Active ingredients: Alfentanil

Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2012 Publisher: Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG UK

Product name and form

Rapifen.

Pharmaceutical Form
Aqueous injection.

Qualitative and quantitative composition

Each ml of Rapifen contains alfentanil hydrochloride 544 micrograms, equivalent to 500 micrograms alfentanil base.

Active Ingredient	Description
Alfentanil	Alfentanil is a short-acting, synthetic, agonist at mu opioid receptors, used for anaesthesia in surgery.

List of Excipients
Sodium chloride Water for injection

Pack sizes and marketing

Colourless glass one-point-cut ampoules (PhEur, Type I).

Pack size: packs of 10 × 2 ml ampoules; packs of 5 and 10 × 10 ml ampoules.

Marketing authorization holder

Janssen-Cilag Limited
50-100 Holmers Farm Way
High Wycombe
Buckinghamshire
HP12 4EG
UK

Marketing authorization dates and numbers

PL 0242/0091

27 July 1983/30 March 2004

Drugs

Drug	Countries
RAPIFEN	Austria, Brazil, Finland, France, Hong Kong, Ireland, Netherlands, New Zealand, Singapore, Tunisia, United Kingdom, South Africa

Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.